Sourbha Dani is a Cardiologist in Burlington, Massachusetts. Dr. Dani is highly rated in 42 conditions, according to our data. His top areas of expertise are Cardiomyopathy, Heart Attack, Atrial Fibrillation, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Benjamin Tillinger is a Cardiologist in Concord, Massachusetts. Dr. Tillinger is highly rated in 38 conditions, according to our data. His top areas of expertise are Adenosine Deaminase 2 Deficiency, Coronary Heart Disease, Arrhythmias, and Heart Failure with Preserved Ejection Fraction (HFpEF).

Jonathan Greene is a Cardiologist in Concord,, Massachusetts. Dr. Greene has been practicing medicine for over 18 years is highly rated in 25 conditions, according to our data. His top areas of expertise are Arrhythmias, Atrial Fibrillation, Thoracic Aortic Aneurysm, and Coronary Heart Disease.

Stephen Dyda is a Cardiologist in Concord, Massachusetts. Dr. Dyda is highly rated in 24 conditions, according to our data. His top areas of expertise are Atrial Fibrillation, Pulmonary Embolism, Deep Vein Thrombosis, and Atherosclerosis.

Dr. Anne Marie Valente is the co-director of the Pregnancy and Cardiovascular Disease Program at Brigham and Women’s Hospital and outpatient director of the Boston Adult Congenital Heart Disease & Pulmonary Hypertension Program. A cardiovascular medicine and adult congenital heart disease specialist, she is also an associate professor of medicine and pediatrics at Harvard Medical School. Dr. Valente is the director of the Adult Congenital Heart Disease and Pulmonary Hypertension Senior Fellowship Program at Harvard Medical School.She received her medical degree from University of Vermont College of Medicine. She completed a combined internal medicine/pediatrics residency, as well as pediatric cardiology, adult cardiovascular disease and cardiovascular magnetic resonance imaging fellowships at Duke University Medical Center. Dr. Valente is board certified in internal medicine, pediatrics, cardiovascular disease and pediatric cardiology.Dr. Valente’s clinical and research interests focus on adult congenital heart disease. Her current research examines heart failure complications in patients with repaired tetralogy of Fallot, a congenital heart defect. She has authored over 50 peer-reviewed publications, as well as numerous chapters and reviews about congenital heart disease imaging and the care of women with heart disease during pregnancy. She has received institutional recognition with the Lerner Research Award and the Watkins Discovery Award as well as research funding from the American Heart Association, the Children’s Miracle Network and the National Heart, Lung and Blood Institute.**The BACH program has been training clinicians in the care of adults with congenital heart disease for several decades.  For more information about the Adult Congenital Heart Disease and Pulmonary Hypertension Senior Fellowship Program at Harvard Medical School, please visit the program website.**The BACH program is closely integrated in the Pregnancy and Cardiovascular Disease Program.  This program involves a multi-disciplinary team dedicated to caring for women with heart disease during pregnancy. More information may be found here. Dr. Valente is highly rated in 43 conditions, according to our data. Her top areas of expertise are Tetralogy of Fallot, Congenital Heart Disease (CHD), Coarctation of the Aorta, Cardiac Ablation, and Heart Transplant.

Dr. Michael J. Landzberg is the organizing founder and director of the Boston Adult Congenital Heart and Pulmonary Hypertension Group (BACH) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also an associate professor of medicine at Harvard Medical School (HMS).Dr. Landzberg received his medical degree from HMS. He completed a residency in internal medicine at Columbia-Presbyterian Medical Center and a fellowship in cardiovascular disease at BWH. Dr. Landzberg is board certified in internal medicine.Dr. Landzberg’s clinical interests include adult congenital heart disease and pulmonary hypertension. The author of more than 140 peer-reviewed publications, Dr. Landzberg’s research focuses on the management of congenital heart disease. Dr. Landzberg is highly rated in 41 conditions, according to our data. His top areas of expertise are Congenital Heart Disease (CHD), Tetralogy of Fallot, Eisenmenger Syndrome, Heart Transplant, and Patent Foramen Ovale Repair.

Patrick T. O'Gara, MD, is the Director of Strategic Planning for the Cardiovascular Division at Brigham and Women’s Hospital, the Watkins Family Distinguished Chair in Cardiology and Professor of Medicine at Harvard Medical School. His clinical activities are focused on patients with valvular heart disease, other structural heart diseases and aortic diseases, although he also maintains a large practice of general cardiology. Since 2001, he has been named annually among the Top Doctors in Boston and the U.S.O'Gara served as President of the American College of Cardiology (ACC) in 2014-15. Additional ACC leadership positions include his roles as Co-Chair of the ACC 2012 Scientific Session program committee, co-directorship of the ACC Board Review Course for Certification and Recertification, and Editor-in-Chief of the ACC Self-Assessment Program (ACCSAP). He served as Chair of the American Heart Association's (AHA's) Council on Clinical Cardiology from 2003-2005 and as the inaugural Editor of Heart Insight magazine from 2006 to 2011. In 2011, he received the Paul Dudley White Award from the Boston Division of the AHA Founder's Affiliate and has also been recognized with the Laennec Master Clinician Award (2011) and the Laennec Clinician Educator Award (2012). O'Gara was Chair of the writing committee for the 2013 ACC/AHA Guideline for the Management of Patients with ST-Elevation MI and has participated in several other guideline, expert consensus, scientific advisory and appropriate use criteria writing groups.He is currently the Vice-Chair for the AHA/ACC Task Force on Clinical Practice Guidelines. He is also the Steering Committee Co-Chair of the National Heart, Lung, and Blood Institute's Cardiothoracic Surgery Network, which has completed 3 groundbreaking, randomized controlled trials in cardiac surgery. O’Gara serves as Associate Editor for JAMA Cardiology and is a member of the Editorial Boards of the Journal of the American College of Cardiology and Circulation. He has lectured widely and authored or co-authored over 250 original manuscripts, chapters, critical reviews, statements and editorials. Dr. O'gara is highly rated in 30 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Bicuspid Aortic Valve, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Usha B. Tedrow is director of the Clinical Cardiac Electrophysiology Program at Brigham and Women’s Hospital’s (BWH) Heart Rhythm Program. A cardiovascular medicine specialist, she is also an assistant professor of medicine at Harvard Medical School (HMS).Dr. Tedrow received her medical degree from HMS. She completed an internal medicine residency and a cardiology fellowship at Massachusetts General Hospital. In addition, she completed a cardiac electrophysiology fellowship at BWH. Dr. Tedrow is board certified in internal medicine, cardiovascular disease and cardiac electrophysiology.Her clinical interests include atrial fibrillation, cardiac resynchronization and ventricular tachycardia. She is currently researching left ventricular mapping and pacing data to analyze novel ablation treatments for structural heart disease. In addition, Dr. Tedrow serves on the editorial board of Circulation: Arrhythmia and Electrophysiology, has authored over 120 peer-reviewed publications and has received research funding from the Heart Rhythm Society. Dr. Tedrow is highly rated in 25 conditions, according to our data. Her top areas of expertise are Ventricular Tachycardia, Arrhythmias, Paroxysmal Supraventricular Tachycardia (PSVT), Cardiac Ablation, and Pacemaker Implantation.

Robert Yeh is a Cardiologist and an Internal Medicine provider in Boston, Massachusetts. Dr. Yeh is highly rated in 22 conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Angina, Percutaneous Coronary Intervention (PCI), and Stent Placement.

Eric Secemsky is a Cardiologist and an Internal Medicine provider in Boston, Massachusetts. Dr. Secemsky has been practicing medicine for over 17 years is highly rated in 19 conditions, according to our data. His top areas of expertise are Peripheral Artery Disease, Pulmonary Embolism, Atherosclerosis, Angioplasty, and Atherectomy.

Roger Laham is a Cardiologist and an Internal Medicine provider in Boston, Massachusetts. Dr. Laham is highly rated in 19 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Atrial Septal Defect (ASD), Mitral Valve Regurgitation, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Paul Zei is a Cardiac Electrophysiologist and Cardiologist at Brigham and Women’s Hospital. He is Director of the BWH Comprehensive Atrial Fibrillation Program, with a faculty appointment at Harvard Medical School.Dr. Zei earned his medical degree and a PhD at Stanford University. He then completed Internal Medicine Internship and Residency, Cardiology Fellowship, and Cardiac Electrophysiology Fellowship training at BWH. After briefly serving on the faculty at BWH, he moved to Stanford University, where he spent eleven years as a faculty member in Cardiology and Cardiac Electrophysiology. At Stanford, Dr. Zei developed a program in complex ablation, a research program in technology innovation, and he also served as the Director of Outpatient Cardiology and ECG services. Dr. Zei then returned to Boston to re-join the faculty at BWH and Harvard Medical School.Dr. Zei’s clinical interests focus on management of complex arrhythmias, with an emphasis on atrial fibrillation, catheter ablation of complex arrhythmias, and device implantation. In his role as Director of BWH’s Comprehensive Atrial Fibrillation Program, Dr. Zei brings together a multi-disciplinary approach to the management of patients with Atrial Fibrillation and leads several research initiatives to better understand and treat patients with this condition. Dr. Zei’s research interests are in understanding the basic underlying mechanisms of cardiac arrhythmias and developing new technologies to treat patients with cardiac arrhythmias. Dr. Zei is highly rated in 18 conditions, according to our data. His top areas of expertise are Atrial Fibrillation, Ventricular Tachycardia, Arrhythmias, Cardiac Ablation, and Pacemaker Implantation.

Dr. Vaduganathan is a cardiologist at Brigham and Women’s Hospital and faculty at Harvard Medical School. He received his medical doctorate and a Master of Public Health degree from Northwestern University. He subsequently completed his residency training in Internal Medicine at Massachusetts General Hospital and fellowship training in Cardiovascular Medicine at Brigham and Women’s Hospital. Dr. Vaduganathan is board certified in internal medicine and cardiovascular disease.Dr. Vaduganathan’s clinical interests surround the intersection between diabetes mellitus, obesity, and heart disease. The author of over 250 peer-reviewed publications, his research focuses on drug development and clinical trials of cardiometabolic therapies. Dr. Vaduganathan is highly rated in 17 conditions, according to our data. His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, Percutaneous Coronary Intervention (PCI), and Heart Transplant.

Martin Maron is a Cardiologist and a Radiologist in Burlington, Massachusetts. Dr. Maron is highly rated in 16 conditions, according to our data. His top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Cardiac Arrest, Heart Transplant, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Maron is currently accepting new patients.

Ethan Rowin is a Cardiologist and a Nuclear Medicine provider in Burlington, Massachusetts. Dr. Rowin has been practicing medicine for over 17 years is highly rated in 16 conditions, according to our data. His top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Heart Transplant, and Aortic Valve Replacement. Dr. Rowin is currently accepting new patients.

Dr. David A. Morrow is the director of the Cardiac Intensive Care Unit (CICU) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School (HMS). He received his medical degree from HMS. He completed an internal medicine residency and a cardiology fellowship at BWH. He is board certified in internal medicine and cardiovascular disease. Dr. Morrow’s clinical interests include cardiac intensive care and ischemic heart disease. At the CICU, he designed and implemented a new multidisciplinary program—the BWH Acute Aortic Syndrome Program and the Shock Team—that helps streamline and improve aortic care and shock management. Dr. Morrow’s research centers on clinical management strategies and novel therapeutics for ischemic heart disease. This includes both stable and unstable ischemic syndromes, with a related focus on the use of cardiovascular biomarkers for risk stratification and clinical decision-making. The author of over 200 peer-reviewed publications, he has received research funding from the National Institutes of Health. Castle Connolly has listed him as one of America’s Top Doctors. Dr. Morrow is highly rated in 16 conditions, according to our data. His top areas of expertise are Cardiogenic Shock, Heart Attack, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Dr. Anju Nohria is the Director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is an Associate Professor of Medicine at Harvard Medical School (HMS).Dr. Nohria received her medical degree from HMS. She completed an internal medicine residency and was a chief resident at Yale-New Haven Hospital. She then completed both a cardiovascular medicine fellowship and a heart failure and transplantation fellowship at BWH. She is board certified in cardiovascular disease and heart failure and transplantation.Dr. Nohria’s clinical interests include cardio-oncology and heart failure and transplantation. The author of over 100 peer-reviewed publications, she currently researches how to evaluate, prevent and treat cardiovascular complications that can arise as a consequence of cancer therapy. Dr. Nohria is highly rated in 15 conditions, according to our data. Her top areas of expertise are Myocarditis, Cardiomyopathy Due to Anthracyclines, Cardiomyopathy, Cardiac Ablation, and Heart Transplant.

Samuel Goldhaber is a Cardiologist in Boston, Massachusetts. Dr. Goldhaber is highly rated in 14 conditions, according to our data. His top areas of expertise are Pulmonary Embolism, Venous Thromboembolism (VTE), Deep Vein Thrombosis, Embolectomy, and Thrombectomy.

Dr. Benjamin M. Scirica is a cardiovascular medicine specialist and Professor of Medicine at Harvard Medical School (HMS). He is a Senior Investigator at the Thrombolysis and Myocardial Infarction (TIMI) Study Group and leads the Accelerator for Clinical Transformation, a group that has developed a series of remote disease management programs.Dr. Scirica received his medical degree from Harvard Medical School. He completed an internal medicine residency and a cardiovascular disease fellowship at BWH. He also completed a research fellowship in cardiovascular disease with the TIMI Study Group at BWH and received a master’s degree in public health from Harvard School of Public Health. Dr. Scirica is board certified in cardiovascular disease. His is an attending physician in the Levine Cardiac Intensive Care Unit and in the Watkins Cardiovascular Clinic at BWH. His research interests center on identifying and applying novel therapeutic and care delivery strategies across the spectrum of cardiometabolic disease. Dr. Scirica is highly rated in 14 conditions, according to our data. His top areas of expertise are Acute Coronary Syndrome, Heart Attack, Cardiac Arrest, Heart Bypass Surgery, and Percutaneous Coronary Intervention (PCI).

Dr. Peter Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and the Mallinckrodt Professor of Medicine at Harvard Medical School (HMS).Dr. Libby received his medical degree from the University of California, San Diego School of Medicine. He completed a residency in internal medicine and a fellowship in cardiovascular disease at Peter Bent Brigham Hospital (now BWH). He also completed a research fellowship in cellular physiology at HMS. Dr. Libby is board certified in internal medicine and cardiovascular disease.The author of some 400 original peer-reviewed publications, some 450 reviews, chapters, or other publications, Dr. Libby also serves as an Editor of the leading textbook of cardiovascular medicine.  Dr. Libby's clinical and research interests include vascular biology, atherosclerosis and preventive cardiology. The research laboratory that Dr. Libby directs studies the messengers created by the body that may produce arterial plaque and blockages, as well as normal and abnormal function of smooth muscle and endothelial cells. Dr. Libby is perennially named a top cardiologist. His research has received funding from the American Heart Association and National Institutes of Health. Dr. Libby has received research recognitions on four continents including the highest research awards from the American Heart Association and American College of Cardiology, the Gold Medal of the European Society of Cardiology, the Anitschkow award from the European Atherosclerosis Society, The Ernst Jung Gold Medal for Medicine, and the Earl Benditt award for vascular biology. Dr. Libby is highly rated in 11 conditions, according to our data. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Abdominal Aortic Aneurysm (AAA), Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Edward Grandin is an Internal Medicine specialist and a Transplant Surgeon in Boston, Massachusetts. Dr. Grandin has been practicing medicine for over 18 years is highly rated in 10 conditions, according to our data. His top areas of expertise are Heart Failure, Pulmonary Edema, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Transplant, and Endoscopy.

Dr. Christine E. Seidman is the director of the Cardiovascular Genetics Program and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is the Thomas W. Smith Professor of Medicine at Harvard Medical School.She received her medical degree from The George Washington School of Medicine and Health Sciences. She completed an internal medicine residency at The Johns Hopkins Hospital and a cardiology fellowship at Massachusetts General Hospital. Dr. Seidman is board certified in internal medicine and cardiovascular disease. Her clinical interests include cardiovascular medicine and genetics.Dr. Seidman also leads the Seidman Laboratory to elucidate genetic causes for heart disease and other disorders. Notable achievements include the discovery of the first genetic cause of congenital heart malformations. Dr. Seidman promotes collaboration between the Laboratory and the BWH Cardiovascular Genetics Center to translate research discoveries into better diagnostics and improved management strategies. She has authored over 300 peer-reviewed articles and received research funding from the Howard Hughes Medical Institute and National Institutes of Health. Dr. Seidman is highly rated in 9 conditions, according to our data. Her top areas of expertise are Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Heart Transplant, and Heart Bypass Surgery.

Dr. Calum Archibald MacRae is Vice Chair for Scientific Innovation in the Department of Medicine at Brigham and Women’s Hospital (BWH), a Professor of Medicine at Harvard Medical School, and an expert member of BWH’s Cardiovascular Genetics Program, which comprehensively evaluates, diagnoses and manages care for inherited cardiac disorder patients. In addition, he is a leading investigator at the BWH Genomics Center and an associate professor of medicine at Harvard Medical School.He received his medical degree from University of Edinburgh College of Medicine. He completed two internal medicine residency programs: one at Wellcome Trust Centre for Neuroimaging in London and the other at BWH. He then completed a fellowship in cardiovascular disease at Massachusetts General Hospital. Dr. MacRae is board certified in internal medicine and cardiovascular disease.Dr. MacRae is a cardiologist and geneticist whose clinical interests include investigating new phenotypes and how research findings—including genomics discoveries—can be systematically implemented into clinical care. His research focuses on the biology and genomics of cardiovascular disease, specifically the biological basis of different arrhythmia susceptibilities. He holds five patents, has authored over 160 peer-reviewed publications and received research funding from the National Institutes of Health’s National Human Genome Research Institute. Dr. Macrae is highly rated in 9 conditions, according to our data. His top areas of expertise are Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), and Cardiac Ablation.

Dr. Jane A. Leopold is the director of the Women's Interventional Cardiology Health Initiative at Brigham and Women’s Hospital (BWH). An interventional cardiovascular medicine specialist, she is also an associate professor of medicine at Harvard Medical School (HMS).She received her medical degree at Boston University School of Medicine. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center and two fellowships at Boston Medical Center—cardiovascular disease and interventional cardiology. Dr. Leopold is board certified in cardiovascular disease and interventional cardiology.Dr. Leopold developed the Women’s Interventional Cardiology Health Initiative at BWH, which uses advanced invasive diagnostic imaging and functional assessment devices to diagnose chest pain syndromes in women. The author of over 100 peer-reviewed publications, Dr. Leopold’s research interests include preclinical and clinical studies in pulmonary arterial hypertension and she is the principal investigator of a National Institutes of Health funded center at BWH to perform deep phenotyping in patients with Groups 1-5 pulmonary hypertension. She also studies mechanisms by which aldosterone influences vascular structure and function and cardiovascular disease in women. Her research has received support from the National Institutes of Health and the American Heart Association. Dr. Leopold is highly rated in 8 conditions, according to our data. Her top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Attack, Angioplasty, and Percutaneous Coronary Intervention (PCI).

Dr. Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.After receiving his medical degree from Yale University School of Medicine, Dr. Waxman completed a residency in internal medicine at Yale New Haven Hospital. He then completed two fellowships: the first at Howard Hughes Medical Institute, and the second in pulmonary and critical care at Yale New Haven Hospital. He is board certified in critical care medicine, internal medicine and pulmonary disease.Dr. Waxman’s clinical interests include pulmonary arterial hypertension (PAH), right heart failure, thromboembolic disease and pulmonary vascular disease. His research focuses on the inflammatory mechanisms of pulmonary vascular remodeling that lead to right heart failure. His research into the regulation of cell death proteins by IL-6 cytokines in mice led to the discovery of a relationship between dyspnea and mitochondrial dysfunction, and resulted in additional clinical studies examining the abnormalities of inflammatory mediators and oxygen extraction in patients with PAH. He has authored over 110 peer-reviewed publications and has received funding from the National Institutes of Health and the National Heart, Lung, and Blood Institute. Dr. Waxman is highly rated in 7 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Interstitial Lung Disease, Lung Transplant, and Thrombectomy.